Sign in
4

Changes in Ownership

Niagen Bioscience, Inc. Filed Acc 0001415889-12-001440

Options or other derivatives

  • Director acquired 125,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Honig Barry C · Director

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2012-08-28 Grant or award : show line 1 in the form Employee Stock Options (right to buy) +125,000 $0.64 2022-08-28 125,000 125,000 D
Loading xslF345X03/form4-09282012_010908.xml…